# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001367644-21-000059
Filing Date
2021-04-05
Accepted
2021-04-05 07:38:33
Documents
18
Period of Report
2021-04-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | ebs-20210404.htm iXBRL | 8-K | 35732
2 | EX-99 | covidvaccinemanufacturin.htm | EX-99 | 8305
8 | GRAPHIC | covidvaccinemanufacturin001.jpg | GRAPHIC | 277610
9 | GRAPHIC | covidvaccinemanufacturin002.jpg | GRAPHIC | 269494
10 | GRAPHIC | covidvaccinemanufacturin003.jpg | GRAPHIC | 33983
| Complete submission text file | 0001367644-21-000059.txt |  | 996566

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | ebs-20210404.xsd | EX-101.SCH | 2484
4 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | ebs-20210404_cal.xml | EX-101.CAL | 764
5 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | ebs-20210404_def.xml | EX-101.DEF | 1710
6 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | ebs-20210404_lab.xml | EX-101.LAB | 25298
7 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | ebs-20210404_pre.xml | EX-101.PRE | 13244
11 | EXTRACTED XBRL INSTANCE DOCUMENT | ebs-20210404_htm.xml | XML | 11300

Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 21803737
SIC: 2834 Pharmaceutical Preparations